Endophthalmitis Associated With XEN Stent Implantation
- PMID: 37059319
- PMCID: PMC10524262
- DOI: 10.1016/j.ajo.2023.04.006
Endophthalmitis Associated With XEN Stent Implantation
Abstract
Purpose: The aim of this study is to report the clinical characteristics, causative organisms, and treatment outcomes in patients presenting with endophthalmitis related to XEN stent implants.
Design: Retrospective, noncomparative consecutive case series.
Methods: Clinical and microbiologic review was performed for 8 patients presenting to the Bascom Palmer Eye Institute Emergency Room between 2021 and 2022 with XEN stent-related endophthalmitis. Data collected included clinical characteristics of patients at presentation, organisms identified in ocular cultures, treatments received, and visual acuity at last follow-up.
Results: The current study included 8 eyes from 8 patients. All cases of endophthalmitis occurred >30 days after implantation of the XEN stent. At the time of presentation, there were external exposures of the XEN stent in 4 of 8 patients. Five of the 8 patients had positive intraocular cultures, all of which were variants of staphylococcus and streptococcus species. Management included intravitreal antibiotics in all patients, explantation of the XEN stent in 5 patients (62.5%), and pars plana vitrectomy in 6 patients (75%). At last follow-up, 6 of the 8 patients (75%) had a visual acuity of hand motion or worse.
Conclusions: Endophthalmitis in the setting of XEN stents results in poor visual outcomes. The most common causative organisms are staphylococcus or streptococcus species. At time of diagnosis, prompt treatment with broad-spectrum intravitreal antibiotics is recommended. Consideration can be made to explant the XEN stent and perform early pars plana vitrectomy.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest: No conflicting relationship exists for any author
Figures
References
-
- Arora KS, Robin AL, Corcoran KJ, Corcoran SL, Ramulu PY. Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries from 1994 to 2012. Ophthalmology. Aug 2015;122(8):1615–1624. - PubMed
-
- Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Current opinion in ophthalmology. Mar 2012;23(2):96–104. - PubMed
-
- Sheybani A, Reitsamer H, Ahmed II. Fluid Dynamics of a Novel Micro-Fistula Implant for the Surgical Treatment of Glaucoma. Investigative ophthalmology & visual science. Jul 2015;56(8):4789–4795. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
